Generation of a predictive melphalan resistance index by drug screen of B-cell cancer cell lines.
<h4>Background</h4>Recent reports indicate that in vitro drug screens combined with gene expression profiles (GEP) of cancer cell lines may generate informative signatures predicting the clinical outcome of chemotherapy. In multiple myeloma (MM) a range of new drugs have been introduced...
Main Authors: | Martin Boegsted, Johanne M Holst, Kirsten Fogd, Steffen Falgreen, Suzette Sørensen, Alexander Schmitz, Anne Bukh, Hans E Johnsen, Mette Nyegaard, Karen Dybkaer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-04-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21559449/?tool=EBI |
Similar Items
-
Proof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myeloma.
by: Martin Bøgsted, et al.
Published: (2013-01-01) -
A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells
by: Kloster Maria, et al.
Published: (2012-11-01) -
Effects of melphalan on tumour cells
by: Gregson, Susan Hilary
Published: (1972) -
Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa.
by: Mette Marcussen, et al.
Published: (2017-01-01) -
Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the Literature
by: Anders Kindberg Boysen, et al.
Published: (2011-01-01)